Press release
Overweight Treatment Market To Expand Based On Agile Supply Chains At A CAGR Of 7.9%
The global Overweight Treatment Market is expected to witness a CAGR of 7.9% and reach US$ 75.1 Bn by the year 2032. With the way in which healthcare data gets accumulated these days (which could be inclusive of medical IoT solutions, DICOM files, and patient records), ultra-modern platforms like data fabrics are in the offing, so that distributed and structured data could be well-managed. This would be healthcare industry's situation in the upcoming period.The overweight treatment market is beginning to take hold across the globe with rising number of investments toward various treatment options. According to Persistence Market Research's latest industry analysis, the global overweight treatment market is valued at around US$ 35.2 Bn, and is expected to exhibit a high CAGR of 7.9% over the forecast period (2022-2032).
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/33086
Weight management methods and treatments are projected to become more popular as out-of-pocket healthcare costs rise in both, emerging and established economies. Per capita healthcare spending is on the rise, which is predicted to fuel the demand for high-quality patient care treatment alternatives. Developing economies such as Brazil, India, and Russia are expected to contribute significantly to the anti-obesity drug development industry.
It has been inferred through various studies that food consumption is directly proportional to the socio-economic status of individuals. The worldwide shift from a predominantly plant-based diet to one rich in meat and processed foods is thought to be a factor in rising obesity rates. Studies have proved that people with better socioeconomic status are more likely to be obese as they have the adequate resources to be spent on food consumption.
Affordability is a major concern for a huge chunk of the population due to the absence of health insurance and government support policies that cover obesity treatment in developing countries.
A major barrier limiting the obesity management industry is the lack of social health insurance and the exclusionary supply of private health insurance plans. Big players can offer certain insurance policies that will cover a big chunk of expenses, and this will also help in attracting more patients.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/33086
Expansion of the overweight treatment market is reliant upon strategic acquisitions and merger activities between market competitors, higher preference for target GLP-1 molecules while developing drug therapies, adoption of telehealth for obesity care, and the emergence of targeted and combination treatment options.
Key Takeaways from Market Study
By treatment, supplements held 89.5% market value share in 2021, and are expected to display a CAGR of 8.1% over the forecast period.
By distribution channel, institutional sales are gaining higher traction for overweight treatment, and held a market value share of 58.2% in 2021.
North America is slated to be the leading regional market for overweight treatment with a projected value share of around 35.2%.
"High incidence of morbid obesity and rising efforts to mitigate indications associated with overweight are driving sales in the overweight treatment market," says an analyst of Persistence Market Research.
Market Competition
Acquisitions, expansion activities, fast-track of FDA approvals, and new product launches are key strategies being adopted by market players to increase their consumer base across geographies and establish a strong market foothold.
In June 2021, the US Food and Drug Administration (FDA) approved Wegovy (semaglutide 2.4mg injection), a Novo Nordisk product for the purpose of chronic weight management.
Apollo Endosurgery received FDA approval for its device Orbera(R) Intragastric Balloon, beneficial for patients with Nonalcoholic fatty liver disease, in March 2021.
In March 2020, VIVUS launched different telemedicine and remote monitoring modules for efficient patient care for health conditions such as obesity.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/33086
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the overweight treatment market in its latest study, presenting a historical demand assessment of 2017 - 2021 and projections for 2022 - 2032.
Access Related Reports-
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Overweight Treatment Market To Expand Based On Agile Supply Chains At A CAGR Of 7.9% here
News-ID: 2635162 • Views: …
More Releases from Persistence Market Research

Surface Disinfectant Market Size to Reach US$ 8.2 Bn by 2032, Growing at 9.5% CA …
The global surface disinfectant market is poised for significant expansion in the coming years, reflecting increasing awareness of hygiene, infection control measures, and the rising adoption of disinfectants across residential, commercial, and industrial settings. According to market projections, the surface disinfectant market is likely to be valued at USD 4.3 billion in 2025 and is expected to reach USD 8.2 billion by 2032, growing at a compound annual growth rate…

Computer-Assisted Surgical Systems Market Growth Supported by Increasing Surgica …
The global computer-assisted surgical (CAS) systems market is on a significant growth trajectory, with its market size projected to reach USD 16.3 billion by 2032, up from an estimated USD 8.7 billion in 2025, registering a robust compound annual growth rate (CAGR) of 9.4% during the forecast period from 2025 to 2032. The market expansion is being driven by rising adoption of advanced surgical technologies, increasing prevalence of chronic and…

Clinical Decision Support Systems Market Forecast Indicates Robust Growth Throug …
The global Clinical Decision Support Systems (CDSS) market is projected to witness significant growth in the coming decade, with an estimated valuation of US$6.3 billion in 2025, expected to reach US$13.1 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 11.0% during the forecast period from 2025 to 2032. The market growth is being fueled by an increasing demand for efficient healthcare delivery, rising adoption of advanced…

Busway Market Transforming Electrical Distribution with Efficient, Safe, and Sca …
Overview of the Market
The global busway market is experiencing significant growth, fueled by increasing demand for efficient, flexible, and safe electrical power distribution solutions across commercial, industrial, and infrastructure sectors. Busway systems, which provide modular, scalable, and easy-to-install alternatives to conventional cable-based power distribution, are increasingly adopted for their space-saving design, enhanced safety, and ability to support high-current applications.
Get a Sample PDF Brochure of the Report (Use Corporate Email…
More Releases for Overweight
Overweight Treatment Market Set for 7.9% CAGR Growth Through 2032, Says Persiste …
The global overweight treatment market is experiencing a significant upswing, driven by a convergence of healthcare challenges and rising public awareness about the health risks associated with obesity. As of 2021, the market was valued at US$ 32.8 Bn, and according to Persistence Market Research, it is expected to grow at a CAGR of 7.9%, reaching US$ 75.1 Bn by 2032. The surge in obesity rates worldwide-now classified as a…
Global Overweight Treatment Market Professional Survey Report 2022-2032 Analysis …
The global Overweight Treatment Market is estimated to reach US$ 75.1 Bn at a CAGR of 7.9% by the year 2032. With remote monitoring comes remote surgery. With digital twinning, this surgery becomes feasible. This could help in saving on prices of development of complex medical products, thereby improvising on the time-to-market metric. This would be the thing with the healthcare vertical in the upcoming period.
The overweight treatment market is…
Overweight Treatment Market: Worldwide Demand, Growth Potential & Opportunity Ou …
The global Overweight Treatment Market is estimated to reach US$ 75.1 Bn at a CAGR of 7.9% by the year 2032. With remote monitoring comes remote surgery. With digital twinning, this surgery becomes feasible. This could help in saving on prices of development of complex medical products, thereby improvising on the time-to-market metric. This would be the thing with the healthcare vertical in the upcoming period.
The overweight treatment market is…
Overweight Treatment Market is anticipated to top a Revenues of nearly USD$ 75.1 …
Overweight Treatment Market 2022
The global overweight treatment market was valued at US$ 32.8 Bn in 2021. Sales of overweight treatment products are set to witness a high compound annual growth rate of 7.9% and be valued at US$ 75.1 Bn by 2032.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/33086
The overweight treatment market is beginning to take hold across the globe with rising number of investments toward various treatment options. According…
Widening Pool of Obese and Overweight Population Drives Demand for Low-calorie F …
The alarming rise in the cases of obesity and overweight conditions has become a major concern for the majority of governments and health organizations worldwide. These conditions pose a great risk to human life and can potentially give birth to other health related problems too. According to a study by the World Health Organization (WHO), overweight conditions and obesity in people have ended up in about 7–41 percent of certain…
Overweight Women Warned About Using Birth Control Patch
FORT WORTH – The maker of the Evra* birth control patch sold in Canada is warning women there that they are at “particularly high risk” of developing blood clots if they are overweight and use the drug.
Canadian drug manufacturer Janssen-Ortho Inc. also says women should not expose the Evra birth control patch to sources of heat such as saunas and whirlpools, based on what the company calls a theoretical risk…